查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541158

2024-2032 年脱髮治疗市场报告（按药物类型、适应症、性别、给药途径、配销通路和地区）

Alopecia Treatment Market Report by Drug Type, Indication, Gender, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球脱髮治疗市场规模达33亿美元。该市场的推动因素包括脱髮日益流行、医疗保健支出的大量投资以及消费者日益增长的美学意识，凸显了外表和自我照顾的重要性。

脱髮治疗市场分析：

主要市场驱动因素：由于医疗保健成本的上升和脱髮（包括斑秃和遗传性脱髮）患病率的上升，对有效治疗替代方案的需求不断增长。

主要市场趋势：脱髮治疗市场的成长是由不断增长的美学意识推动的，受到社交媒体和理想美容标准的影响，而对脱髮状况的认识不断提高，鼓励人们寻求脱髮治疗的医疗援助。

地理趋势：脱髮治疗市场预测显示将大幅成长，尤其是在美国等国家，医疗保健支出的成长推动了市场扩张。由于美容问题的增加，城市社区和年轻人对脱髮治疗的需求不断增加。

竞争格局：一些主要的脱髮治疗公司包括 Aclaris Therapeutics Inc.、Cellmid Limited、Cipla Limited、Dr. Reddy's Laboratories Ltd.、GlaxoSmithKline plc、HCell Inc.、Johnson & Johnson、Merck & Co. Inc.、Pfizer Inc.。 、大正製药控股有限公司、梯瓦製药工业股份有限公司等。

挑战与机会：挑战包括与特定治疗相关的高昂费用、有限的保险范围以及对特定干预措施可能产生的不良反应。脱髮治疗市场近期的机会包括提供高效、微创治疗的技术发展，以及透过集中行销和宣传工作扩大市场范围。

脱髮治疗市场趋势：

脱髮盛行率增加

雄性秃是男性和女性中常见的一种常见的脱髮形式。根据美国皮肤病学会杂誌(JAAD) 2023 年发表的调查显示，脱髮对不同种族和性别群体的影响不同，15% 的停经后女性和超过50% 的老年男性都会经历脱髮，而头髮稀疏最早就开始出现作为青春期。除此之外，推动脱髮治疗市场向前发展的主要因素之一是脱髮患病率不断上升，其中包括遗传性脱髮和斑秃等疾病。国家斑秃基金会估计，有 670 万美国人和全世界约 1.6 亿人患有斑秃或可能患有斑秃。目前，美国约有 70 万人患有斑秃。此外，全世界约有 2% 的人患有斑秃，这凸显了这种导致脱髮的疾病的广泛流行。根据脱髮治疗市场概况，随着越来越多的人意识到并寻求有效的治疗解决方案，该行业的需求正在上升。因此，由于医疗技术的进步和广泛的治疗选择，人们开始求助于头髮修復的医疗援助，导致脱髮治疗市场大幅扩张。

医疗保健支出增加

全球医疗保健支出不断增加是推动脱髮治疗市场成长的关键因素。 2020 年，全球医疗保健支出平均成长21%。增加。在有资料的国家中，比利时的人均医疗支出增幅最大，2021年至2022年间增长了9.6%。脱髮治疗。因此，财务能力的增强和可支配收入的增加，使更多的人能够负担得起脱髮治疗，从而促进了市场的成长。

审美意识不断增强

此外，全球个人对外表和美学意识的日益重视，大大促进了脱髮治疗市场的扩张。国际毛髮修復外科协会 (ISHRS) 进行的一项调查显示，ISHRS 成员平均治疗了 165 名手术患者和 396 名非手术患者。此外，2021 年，大约三分之二(65%) 的ISHRS 会员进行了0-199 次毛髮修復手术，平均每位会员进行了179 次手术，而78% 的ISHRS 会员进行了0-19 次毛髮修復手术。 2021 年，会员平均每月完成 14 例头髮修復手术。坚持感知的美学理想和文化压力的需要导致了对有效头髮修復选择的显着需求。因此，随着越来越多的人寻找改善外观和解决脱髮问题的方法，脱髮治疗市场正在不断增长。

脱髮治疗市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据药物类型、适应症、性别、给药途径和配销通路对市场进行了分类。

按药物类型细分：

米诺地尔

非那雄胺

其他的

米诺地尔占据大部分市场份额

该报告根据药物类型对市场进行了详细的细分和分析。这包括米诺地尔、非那雄胺等。根据该报告，米诺地尔代表了最大的部分。

米诺地尔是一种常用药物，可有效治疗多种形式的脱髮。米诺地尔是治疗男性和女性型秃头的一种流行且易于使用的治疗选择。在许多地方都可以透过柜檯购买。这种 FDA 核准的药物有多种形式，包括泡沫剂和局部治疗剂。它可以减缓脱髮，刺激头髮生长，并增加毛囊的血液供应。由于与处方药相比其价格相对便宜且具有促进头髮生长的功效，因此被广泛采用。例如，根据Research Gate 的一项研究，患者接受低剂量口服米诺地尔(LDOM) 治疗至少3 个月，作为治疗任何类型脱髮的方法，这为治疗脱髮提供了良好的安全性，但没有任何生命- 威胁性的不良反应。因此，脱髮人数的增加导致采用米诺地尔来治疗脱髮，从而积极产生脱髮治疗市场收入。

按指示细分：

雄性秃

斑秃

全秃

其他的

雄性秃占业界最大份额

报告还提供了基于指示的详细市场细分和分析。这包括雄性秃、斑秃、全秃等。报告称，雄​​性秃占据了最大的市场。

雄性秃，通常称为男性或女性型秃髮，占据了市场上最大的部分。这主要是由于雄性秃在全球盛行，影响了很大一部分男性和女性。此外，人们对治疗方案的认识和接受度不断提高，加上局部治疗、口服药物和植髮手术等治疗技术的进步，进一步推动了市场的成长。因此，主要参与者正在推出先进的产品变体来满足这些需求。例如，2024年2月，临床阶段的再生医学公司Pelage Pharmaceuticals创造了一种治疗脱髮的新型疗法，同时宣布完成1,675万美元的A轮融资。这笔资金将有助于开发针对雄性秃（型秃髮）和其他类型脱髮（包括化疗引起的脱髮）的一流治疗方法。 GV 领投，并获得 Main Street Advisors、Visionary Ventures 和 YK BioVentures 的支持。因此，人们越来越关注脱髮的美观和心理影响，导致对有效治疗解决方案的需求不断增长，从而巩固了雄激素性脱髮在脱髮治疗市场前景中的地位。

按性别划分：

男性

女性

女性代表主导细分市场

该报告根据性别对市场进行了详细的细分和分析。这包括男性和女性。根据该报告，女性占最大部分。

女性脱髮的盛行率不断上升，加上人们对脱髮药物治疗的认识和接受度不断提高，正在影响市场的成长。由于美学问题和脱髮的心理影响，女性正在寻求有效的脱髮解决方案，从而导致对药物和美容治疗的巨大需求。此外，专为女性脱髮设计的产品范围不断扩大，包括局部解决方案、口服药物以及富血小板血浆（PRP）和低强度雷射疗法（LLLT）等先进疗法，进一步推动了该细分市场的成长。根据美国皮肤病学会(AAD) 协会的规定，米诺地尔被认为是经美国食品药物管理局(FDA) 批准用于治疗女性型秃头(FPHL) 的非处方药物，因为FPHL 可以透过以下方法治疗：含有 2% 或 5% 米诺地尔的药物。因此，对以女性为中心的行销策略的日益关注以及女性自我照顾和健康的上升趋势也有助于脱髮治疗市场的扩大。

依给药途径分类：

口服

专题

可注射

主题在市场上表现出明显的主导地位

报告还提供了基于给药途径的详细市场细分和分析。这包括口服、局部和注射。报告显示，外用占据了最大的市场份额。

主题细分市场占有最大份额，因为其易于使用而被广泛使用和接受。包括米诺地尔和皮质类固醇在内的局部疗法是非侵入性的，可以直接施用到受影响的区域，并且比口服和注射疗法具有更少的全身性不良反应，并且通常是防止脱髮的第一道防线。这种给药途径因其在不需要医生护理的情况下想要快速修復的患者的欢迎而受到欢迎。据克利夫兰诊所称，皮质类固醇和其他抗发炎药物可用于治疗脱髮。它以软膏、霜剂或泡沫的形式局部涂抹（皮肤），或註射到头皮或其他区域进行治疗。

按配销通路划分：

医院

零售药局

网路药局

医院主导市场

该报告根据配销通路对市场进行了详细的细分和分析。这包括医院、零售药局和网路药局。报告称，医院占最大部分。

医院的主导地位归因于医院环境中广泛的基础设施和专业的医疗专业知识，这确保了脱髮患者的全面诊断和量身定制的治疗计划。医院通常提供一系列治疗选择，包括处方药、先进的医疗程序和支持性护理，使它们成为寻求专业和有效的脱髮治疗的个人的首选。因此，与医院护理相关的信任和可靠性有助于其在脱髮治疗市场中的领先地位。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美引领市场，占据最大的脱髮治疗市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是脱髮治疗最大的区域市场。

北美脱髮治疗市场最近的发展特点是医疗基础设施健全、脱髮患病率不断上升以及对可用治疗方案的认识不断提高。主要製药公司的存在和医疗技术的进步进一步支撑了该地区的市场。例如，2023年6月，美国食品药物管理局（FDA）宣布批准耶鲁大学皮肤科医生Brett King博士开发的Janus激酶（JAK）抑制剂ritlecitinib，他与辉瑞製药公司合作进行了一系列临床试验与利特西替尼。它是一种口服药物，用于治疗青少年和成人的斑秃，名为 Litfulo。此外，对美容手术的日益增长和更高的可支配收入使消费者能够花在脱髮治疗上，这积极增加了北美的脱髮治疗需求。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。脱髮治疗行业的一些主要市场参与者包括 Aclaris Therapeutics Inc.、Cellmid Limited、Cipla Limited、Dr. Reddy's Laboratories Ltd.、葛兰素史克公司、HCell Inc.、强生公司、默克公司、辉瑞公司.、大正製药控股有限公司、梯瓦製药工业股份有限公司等

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

全球市场的主要参与者正在积极参与多项策略性倡议，以保持竞争优势。他们大力投资研发，以引入创新的治疗方法和疗法，以提高疗效并减少副作用。此外，这些参与者正致力于透过进入新兴市场并利用对脱髮解决方案不断增长的需求来扩大其全球影响力。与皮肤科诊所和医疗保健提供者的合作和伙伴关係变得越来越普遍，以确保更广泛的分销网络。此外，一些公司正在利用数位行销和电子商务平台来推广其产品并覆盖更广泛的消费者群体，强调便利性和可及性。例如，2023 年3 月6 日，Sun Pharmaceutical Industries Limited 及其子公司和/或联营公司（称为Sun Pharma）宣布成功完成对Concert Pharmaceuticals, Inc. 的收购。正在开发deuruxolitinib 是一种新型氘化口服 JAK1/2 抑制剂，可用于治疗中度至重度斑秃成人患者。

脱髮治疗市场新闻：

2023 年 12 月 5 日：Aclaris Therapeutics, Inc. 是一家致力于开发免疫发炎性疾病创新疗法的临床阶段生物製药公司，宣布与 Sun Pharmaceutical Industries, Inc.（现为 Sun Pharma）签署独家专利授权协议。 Aclaris 已授予 Sun Pharma 使用 deuruxolitinib、Sun Pharma 的 JAK 抑制剂或其他同位素形式的 ruxolitinib 治疗斑秃 (AA) 和雄激素性脱髮 (AGA) 的某些专利的独家权利。其中包括 1500 万美元的预付款、监管和商业里程碑以及特许权使用费。 Aclaris 仅从第三方获得专利许可，由于单独的合约承诺，有义务分享从 Sun Pharma 收到的部分对价。

2024 年 5 月 14 日：REVIAN Inc. 是一家专门利用精确波长的 LED 光进行头髮和皮肤再生的医疗技术公司，宣布参加定于达拉斯举行的 2024 年皮肤病研究学会年会。活动期间，Jacob Kocher 博士展示了一张资料，其中详细介绍了Revian 的专利波长组合可将双氢睪酮(DHT) 产量减少74%，显着优于行业标准非那雄胺，后者在使用后24 小时内将DHT 减少了38%。众所周知，双氢睪酮在雄性秃或秃髮的发展中起着至关重要的作用。

本报告回答的关键问题

  • 2023年全球脱髮治疗市场规模是多少
  • 2024-2032年全球脱髮治疗市场的预期成长率是多少
  • 推动全球脱髮治疗市场的关键因素是什么
  • COVID-19 对全球脱髮治疗市场有何影响
  • 根据药物类型，全球脱髮治疗市场的细分情况如何
  • 根据适应症，全球脱髮治疗市场的细分是什么
  • 全球脱髮治疗市场按性别分類的情况如何
  • 根据给药途径，全球脱髮治疗市场的细分情况如何
  • 基于配销通路的全球脱髮治疗市场的细分是什么
  • 10. 全球脱髮治疗市场的重点区域有哪些？
  • 11. 全球脱髮治疗市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 2023年全球脱髮治疗市场规模有多大？ 2024-2032年全球脱髮治疗市场的预期成长率是多少？
  • 推动全球脱髮治疗市场的关键因素是什么？
  • COVID-19 对全球脱髮治疗市场有何影响？
  • 根据药物类型，全球脱髮治疗市场的细分情况如何？
  • 根据适应症，全球脱髮治疗市场的细分情况如何？
  • 全球脱髮治疗市场按性别分類的情况如何？
  • 根据给药途径，全球脱髮治疗市场的细分情况如何？
  • 基于配销通路的全球脱髮治疗市场的细分是什么？
  • 全球脱髮治疗市场的关键地区有哪些？
  • 全球脱髮治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球脱髮治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依药物类型

  • 米诺地尔
    • 市场趋势
    • 市场预测
  • 非那雄胺
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依迹象

  • 雄性秃
    • 市场趋势
    • 市场预测
  • 斑秃
    • 市场趋势
    • 市场预测
  • 全秃
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依性别

  • 男性
    • 市场趋势
    • 市场预测
  • 女性
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：依管理途径

  • 口服
    • 市场趋势
    • 市场预测
  • 专题
    • 市场趋势
    • 市场预测
  • 可注射
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按配销通路

  • 医院
    • 市场趋势
    • 市场预测
  • 零售药局
    • 市场趋势
    • 市场预测
  • 网路药局
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aclaris Therapeutics Inc.
    • Cellmid Limited
    • Cipla Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • HCell Inc.
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Taisho Pharmaceutical Holdings Co. Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A4147

The global alopecia treatment market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The market is driven by the increasing prevalence of alopecia, significant investment in healthcare expenditure, and the growing aesthetic consciousness among consumers highlighting the importance of appearance and self-care.

Alopecia Treatment Market Analysis:

Major Market Drivers: The growing need for efficient treatment alternatives is due to the rise in healthcare costs and the rising prevalence of alopecia, including alopecia areata and hereditary hair loss.

Key Market Trends: The alopecia treatment market growth is driven by the growing aesthetic consciousness, influenced by social media and ideal beauty standards, and increasing awareness about alopecia conditions is encouraging people to seek medical assistance for hair loss treatment.

Geographical Trends: The alopecia treatment market forecasts indicate a substantial increase, especially in nations like the US, where growing healthcare spending fuels market expansion. Urban communities and younger people are increasing the demand for alopecia treatments owing to increased cosmetic concerns.

Competitive Landscape: Some of the major alopecia treatment companies include Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd, Teva Pharmaceutical Industries Ltd., among many others.

Challenges and Opportunities: The challenges consist of the exorbitant expenses linked to specific treatments, restricted insurance coverage, and possible adverse reactions to specific interventions. The alopecia treatment market recent opportunities include technical developments that offer efficient and minimally invasive treatments and the expansion of market reach through focused marketing and awareness efforts.

Alopecia Treatment Market Trends:

Increasing Prevalence of Alopecia

Androgenetic alopecia is a prevalent form of patterned hair loss that is seen in men and women. As per the Journal of the American Academy of Dermatology International (JAAD) published survey in 2023, alopecia affects different racial and gender groups differently, 15% of postmenopausal women and over 50% of elderly males experience it, while thinning hair can begin as early as puberty. Besides this, one of the main factors driving the alopecia treatment market forward is the rising prevalence of alopecia, which includes inherited hair loss and disorders like alopecia areata. The National Alopecia Areata Foundation estimates that 6.7 million Americans and about 160 million individuals worldwide have alopecia areata or may acquire it. Currently, alopecia areata affects about 700,000 persons in the United States. Furthermore, alopecia areata affects about 2% of people worldwide, underscoring the disorder's widespread prevalence that causes hair loss. As per the alopecia treatment market overview, demand in the industry is rising as more individuals become aware and look for efficient treatment solutions. Therefore, people are resorting to medical aid for hair restoration due to advances in medical technology and a wide range of treatment options accessible, leading to a considerable expansion in the market for alopecia therapy.

Rising Healthcare Expenditure

The escalating healthcare expenditure worldwide is a pivotal factor driving the growth trajectory of the alopecia treatment market. Global healthcare spending increased by 21% on average in 2020. This number has increased even further by 2021, when it was a startling 25% higher than in 2019. Moreover, the per capita health spending increased in most peer countries between 2021 and 2022. A moderate 2.9% growth in per capita health spending was reported in the US, Australia (2.4%), Canada (0.7%), and the UK (0.5%). Among the countries for whom data was available, Belgium experienced the largest growth in per capita health spending, rising 9.6% between 2021 and 2022. Notably, developed nations show an especially notable increase in healthcare spending, indicating the willingness of individuals to spend money on cutting-edge medical treatments, such as alopecia treatments. Hence, the growing financial capacity and increased disposable income, allow more people to afford alopecia treatments, thus contributing to the market growth.

Growing Aesthetic Consciousness

Furthermore, the growing emphasis on physical appearance and aesthetic consciousness among individuals globally is significantly contributing to the expansion of the alopecia treatment market. A survey conducted by the International Society of Hair Restoration Surgery (ISHRS) revealed that ISHRS members treated on average 165 surgical patients and 396 non-surgical patients. Moreover, ISHRS members performed surgical procedures between 0-199 hair restoration in 2021 by around two-thirds (65%) of ISHRS members, with an average member performing 179 procedures, while 78% of ISHRS members performed 0-19 hair restoration surgical operations. Members completed an average of 14 hair restoration surgical procedures per month in 2021. As a result, this rising figure illustrates increased self-consciousness among individuals about their appearance, which is exacerbated by social media's effect and the representation of ideal beauty standards. The need to adhere to perceived aesthetic ideals and cultural pressures has resulted in a noteworthy demand for effective hair restoration options. Consequently, the market for alopecia treatments is growing as more people look for ways to improve their physical appearance and deal with their hair loss issues.

Alopecia Treatment Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on drug type, indication, gender, route of administration, and distribution channel.

Breakup by Drug Type:

Minoxidil

Finasteride

Others

Minoxidil accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the drug type. This includes minoxidil, finasteride, and others. According to the report, minoxidil represented the largest segment.

Minoxidil is a commonly used medication that effectively treats alopecia in many forms. Minoxidil is a popular and easily accessible therapy option for male and female pattern hair loss. It is available over the counter in many locations. This FDA-approved drug comes in several forms, including foams and topical treatments. It slows down hair loss, stimulates hair growth, and increases blood supply to hair follicles. It is widely adopted due to its relative affordability when compared to prescription drugs and its efficacy in encouraging hair growth. For instance, as per a study by Research Gate, patients were treated with low-dose oral minoxidil (LDOM) for at least 3 months as a treatment for any type of alopecia, which offers a good safety profile to treat hair loss without any life-threatening adverse effects. Thus, the increasing number of alopecia is resulting in the adoption of minoxidil to treat alopecia, positively generating alopecia treatment market revenue.

Breakup by Indication:

Androgenic Alopecia

Alopecia Areata

Alopecia Totalis

Others

Androgenic alopecia holds the largest share of the industry

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes androgenic alopecia, alopecia areata, alopecia totalis, and others. According to the report, androgenic alopecia accounted for the largest market share.

Androgenic alopecia, commonly known as male or female pattern baldness, holds the largest segment in the market. It is primarily due to the high prevalence of androgenic alopecia globally, which affects a significant portion of men and women. Additionally, the rising awareness and acceptance of treatment options, coupled with advances in therapeutic techniques such as topical treatments, oral medications, and hair transplant procedures, have further propelled the market growth. Hence key players are introducing advanced product variants to meet these needs. For instance, in February 2024, Pelage Pharmaceuticals, a clinical-stage regenerative medicine company created a novel treatment for hair loss, while announcing the completion of $16.75 million Series A fundraising. The funding will assist the development of a first-in-class treatment for androgenetic alopecia (pattern baldness) and other kinds of alopecia, including chemotherapy-induced hair loss. GV is leading the investment, which is also supported by Main Street Advisors, Visionary Ventures, and YK BioVentures. As a result, the increasing focus on aesthetic appearance and the psychological impact of hair loss has led to the rising demand for effective treatment solutions, solidifying androgenic alopecia's position in the alopecia treatment market outlook.

Breakup by Gender:

Male

Female

Female represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on gender. This includes male and female. According to the report, females represented the largest segment.

The growing prevalence of alopecia in females coupled with a growing awareness and acceptance of medical treatments for hair loss are influencing the market growth. Women are seeking effective solutions for alopecia due to aesthetic concerns and the psychological impact of hair loss, leading to a significant demand for pharmaceutical and cosmetic treatments. Additionally, the expansion of product offerings specifically designed for female alopecia, including topical solutions, oral medications, and advanced therapies such as platelet-rich plasma (PRP) and low-level laser therapy (LLLT), has further propelled the growth of this segment. As per the American Academy of Dermatology (AAD) association, minoxidil is recognized as an over-the-counter medication approved by the US Food and Drug Administration (FDA) for treating female pattern hair loss (FPHL), since FPHL can be treated with medications that include 2% or 5% minoxidil. Therefore, the growing focus on female-centric marketing strategies and the rising trend of self-care and wellness among women are also contributing to the expansion of alopecia treatment market.

Breakup by Route of Administration:

Oral

Topical

Injectable

Topical exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, topical, and injectable. According to the report, topical accounted for the largest market share.

Topical segment holds the largest share, as it is widely used and accepted owing to its ease of use. Topical therapies, including minoxidil and corticosteroids, are non-invasive, can be administered directly to the afflicted area, and have fewer systemic adverse effects than oral and injectable options, and are frequently the first line of defense against hair loss. This route of administration is attributed to its popularity among patients who want quick fixes that work well without requiring physician care. According to the Cleveland Clinic, corticosteroids and other anti-inflammatory medications can be used to treat alopecia. It is rubbed topically (into the skin) as an ointment, cream, or foam, or injected into the scalp or other regions for the treatment.

Breakup by Distribution Channel:

Hospitals

Retail Pharmacies

Online Pharmacies

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospitals, retail pharmacies, and online pharmacies. According to the report, hospitals represented the largest segment.

Hospital dominance is attributed to the extensive infrastructure and specialized medical expertise available in hospital settings, which ensure comprehensive diagnosis and tailored treatment plans for alopecia patients. Hospitals often provide a range of therapeutic options, including prescription medications, advanced medical procedures, and supportive care, making them a preferred choice for individuals seeking professional and effective alopecia management. Hence, the trust and reliability associated with hospital care contribute to their leading position in the alopecia treatment market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest alopecia treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for alopecia treatment.

The North America alopecia treatment market recent developments are marked by the robust healthcare infrastructure, increasing prevalence of alopecia, and increased awareness about available treatment options. The presence of major pharmaceutical companies and advancements in medical technology further bolster the market in this region. For instance, in June 2023, the U.S. Food and Drug Administration (FDA) announced the approval of ritlecitinib, a Janus kinase (JAK) inhibitor by Yale dermatologist Dr. Brett King, who worked with pharmaceutical company Pfizer for conducting a series of clinical trials with ritlecitinib. It is for the treatment of alopecia areata in adolescents and adults which is an oral medication under the name Litfulo. Furthermore, the growing inclination toward aesthetic procedures and a higher disposable income enable consumers to spend on treatments for hair loss, which is positively increasing the alopecia treatment demand in North America.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the alopecia treatment industry include Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd, Teva Pharmaceutical Industries Ltd., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The key players in the global market are actively engaged in several strategic initiatives to maintain their competitive edge. They are heavily investing in research and development to introduce innovative treatments and therapies that offer enhanced efficacy and fewer side effects. Additionally, these players are focusing on expanding their global presence by entering emerging markets and capitalizing on the growing demand for hair loss solutions. Collaborations and partnerships with dermatological clinics and healthcare providers are becoming increasingly common to ensure a wider distribution network. Moreover, several companies are leveraging digital marketing and e-commerce platforms to promote their products and reach a broader consumer base, emphasizing convenience and accessibility. For instance, on 6 March 2023, Sun Pharmaceutical Industries Limited along with its subsidiaries and/or associated companies, known as Sun Pharma announced the successful completion of its acquisition of Concert Pharmaceuticals, Inc. Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company developing deuruxolitinib, a novel deuterated oral JAK1/2 inhibitor, for the potential treatment of adult patients with moderate to severe alopecia areata.

Alopecia Treatment Market News:

5 December 2023: Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for immuno-inflammatory diseases, announced an exclusive patent license agreement with Sun Pharmaceutical Industries, Inc., now Sun Pharma. Aclaris has granted Sun Pharma exclusive rights to certain patents for the use of deuruxolitinib, Sun Pharma's JAK inhibitor, or other isotopic forms of ruxolitinib, for the treatment of alopecia areata (AA) and androgenetic alopecia (AGA). It includes an upfront payment of $15 million, and regulatory and commercial milestones, and royalties. Aclaris licenses the patents exclusively from a third party and is obligated to share a portion of the consideration received from Sun Pharma due to separate contractual commitments.

14 May 2024: REVIAN Inc., a medical technology company specializing in the use of precise wavelengths of LED light for hair and skin rejuvenation, announced its participation in the 2024 Society for Investigative Dermatology Annual Meeting, scheduled in Dallas. During the event, Dr. Jacob Kocher presented a poster detailing data that demonstrates Revian's patented combination of wavelengths reduces Dihydrotestosterone (DHT) production by 74%, significantly outperforming the industry standard finasteride, which achieved a 38% reduction in DHT at 24 hours post-treatment in the same in vitro experiment. DHT is known to play a crucial role in the development of pattern hair loss androgenic alopecia or pattern baldness.

Key Questions Answered in This Report

  • 1. What was the size of the global alopecia treatment market in 2023?
  • 2. What is the expected growth rate of the global alopecia treatment market during 2024-2032?
  • 3. What are the key factors driving the global alopecia treatment market?
  • 4. What has been the impact of COVID-19 on the global alopecia treatment market?
  • 5. What is the breakup of the global alopecia treatment market based on the drug type?
  • 6. What is the breakup of the global alopecia treatment market based on the indication?
  • 7. What is the breakup of the global alopecia treatment market based on gender?
  • 8. What is the breakup of the global alopecia treatment market based on the route of administration?
  • 9. What is the breakup of the global alopecia treatment market based on the distribution channel?
  • 10. What are the key regions in the global alopecia treatment market?
  • 11. Who are the key players/companies in the global alopecia treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alopecia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Minoxidil
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Finasteride
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Androgenic Alopecia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Alopecia Areata
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Alopecia Totalis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Gender

  • 8.1 Male
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Female
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Topical
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Online Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Aclaris Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
    • 16.3.2 Cellmid Limited
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Cipla Limited
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Dr. Reddy's Laboratories Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 GlaxoSmithKline plc
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 HCell Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Johnson & Johnson
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Merck & Co. Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Pfizer Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Taisho Pharmaceutical Holdings Co. Ltd
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Teva Pharmaceutical Industries Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Alopecia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Alopecia Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Alopecia Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Alopecia Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Alopecia Treatment Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Alopecia Treatment Market: Breakup by Gender (in %), 2023
  • Figure 7: Global: Alopecia Treatment Market: Breakup by Route of Administration (in %), 2023
  • Figure 8: Global: Alopecia Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 9: Global: Alopecia Treatment Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Alopecia Treatment (Minoxidil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Alopecia Treatment (Minoxidil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Alopecia Treatment (Finasteride) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Alopecia Treatment (Finasteride) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Alopecia Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Alopecia Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Alopecia Treatment (Androgenic Alopecia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Alopecia Treatment (Androgenic Alopecia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Alopecia Treatment (Alopecia Areata) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Alopecia Treatment (Alopecia Areata) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Alopecia Treatment (Alopecia Totalis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Alopecia Treatment (Alopecia Totalis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Alopecia Treatment (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Alopecia Treatment (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Alopecia Treatment (Male) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Alopecia Treatment (Male) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Alopecia Treatment (Female) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Alopecia Treatment (Female) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Alopecia Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Alopecia Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Alopecia Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Alopecia Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Alopecia Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Alopecia Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Alopecia Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Alopecia Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Alopecia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Alopecia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Alopecia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Alopecia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Alopecia Treatment Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Alopecia Treatment Industry: SWOT Analysis
  • Figure 90: Global: Alopecia Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Alopecia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alopecia Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Alopecia Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 3: Global: Alopecia Treatment Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Alopecia Treatment Market Forecast: Breakup by Gender (in Million US$), 2024-2032
  • Table 5: Global: Alopecia Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 6: Global: Alopecia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 7: Global: Alopecia Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Alopecia Treatment Market: Competitive Structure
  • Table 9: Global: Alopecia Treatment Market: Key Players